Journal article icon

Journal article

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling.

Abstract:
Mutations in PIK3CA are very frequent in cancer and lead to sustained PI3K pathway activation. The impact of acute expression of mutant PIK3CA during early stages of malignancy is unknown. Using a mouse model to activate the Pik3ca H1047R hotspot mutation in the heterozygous state from its endogenous locus, we here report that mutant Pik3ca induces centrosome amplification in cultured cells (through a pathway involving AKT, ROCK and CDK2/Cyclin E-nucleophosmin) and in mouse tissues, and increased in vitro cellular tolerance to spontaneous genome doubling. We also present evidence that the majority of PIK3CA H1047R mutations in the TCGA breast cancer cohort precede genome doubling. These previously unappreciated roles of PIK3CA mutation show that PI3K signalling can contribute to the generation of irreversible genomic changes in cancer. While this can limit the impact of PI3K-targeted therapies, these findings also open the opportunity for therapeutic approaches aimed at limiting tumour heterogeneity and evolution.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1038/s41467-017-02002-4

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9537-4045



Publisher:
Nature Publishing Group
Journal:
Nature Communications More from this journal
Volume:
8
Issue:
1
Pages:
1773
Publication date:
2017-11-01
Acceptance date:
2017-11-01
DOI:
EISSN:
2041-1723
ISSN:
2041-1723
Pmid:
29170395


Language:
English
Keywords:
Pubs id:
pubs:802690
UUID:
uuid:4fbb5836-e555-46e9-b7bf-39ad31297fb6
Local pid:
pubs:802690
Source identifiers:
802690
Deposit date:
2018-02-27

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP